ContractNon-Qualified Stock Option Agreement • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products • Delaware
Contract Type FiledMay 9th, 2017 Company Industry JurisdictionThis NON-QUALIFIED STOCK OPTION AGREEMENT (this "Agreement") is made and entered into as of March 15, 2017, by and between CV Sciences, Inc., a Delaware corporation (the "Company") and Michael Mona, Jr. ("Optionee").
AMENDMENT TO STOCK OPTION AGREEMENTStock Option Agreement • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 9th, 2017 Company IndustryThis Amendment to Stock Option Agreement (this “Amendment”) is entered into by and between MICHAEL MONA, JR., an individual (“Executive”), and CV SCIENCES, INC., a Delaware corporation (the “Company”) as of March 16, 2017 (the “Effective Date”), with reference to the following facts:
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 9th, 2017 Company IndustryThis Amendment to Employment Agreement (this “Amendment”) is entered into by and between MICHAEL MONA, JR., an individual (“Executive”), and CV SCIENCES, INC., a Delaware corporation (the “Company”) as of March 16, 2017 (the “Effective Date”), with reference to the following facts:
AMENDMENT TO STOCK OPTION AGREEMENTStock Option Agreement • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 9th, 2017 Company IndustryThis Amendment to Stock Option Agreement (this “Amendment”) is entered into by and between JOSEPH DOWLING, an individual (“Executive”), and CV SCIENCES, INC., a Delaware corporation (the “Company”) as of March 16, 2017 (the “Effective Date”), with reference to the following facts:
AMENDMENT TO STOCK OPTION AGREEMENTStock Option Agreement • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 9th, 2017 Company IndustryThis Amendment to Stock Option Agreement (this “Amendment”) is entered into by and between MICHAEL MONA, III, an individual (“Executive”), and CV SCIENCES, INC., a Delaware corporation (the “Company”) as of March 16, 2017 (the “Effective Date”), with reference to the following facts:
AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF REORGANIZATIONAgreement and Plan of Reorganization • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 9th, 2017 Company IndustryThis Amendment No. 1 to Agreement and Plan of Reorganization (this “Amendment”) is entered into as of March 16, 2017 (the “Effective Date”), by and between (i) CV SCIENCES, INC., a Delaware corporation (the “Company”), (ii) CANNAVEST Acquisition LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (“LLC”), and (iii) The Starwood Trust, as the Shareholder Representative (the “Shareholder Representative”) (the Company, LLC and the Shareholder Representative are collectively referred to herein as, the “Parties”). Capitalized terms not defined herein shall have their respective meanings as set forth in the Agreement (defined below).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2017 • CV Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 9th, 2017 Company IndustryThis Amendment to Employment Agreement (this “Amendment”) is entered into by and between MICHAEL MONA III, an individual (“Executive”), and CV SCIENCES, INC., a Delaware corporation (the “Company”) as of March 16, 2017 (the “Effective Date”), with reference to the following facts: